4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Gamma Hydroxybutyric Acid is combined with Vortioxetine.
Abiraterone
The serum concentration of Vortioxetine can be increased when it is combined with Abiraterone.
Acepromazine
The risk or severity of adverse effects can be increased when Acepromazine is combined with Vortioxetine.
Advertisement
Aceprometazine
The risk or severity of adverse effects can be increased when Aceprometazine is combined with Vortioxetine.
Acetophenazine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Acetophenazine.
Alfaxalone
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Alfaxalone.
Advertisement
Alfentanil
The risk or severity of adverse effects can be increased when Alfentanil is combined with Vortioxetine.
Almotriptan
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Almotriptan.
Alphaprodine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Alphaprodine.
Advertisement
Alprazolam
The risk or severity of adverse effects can be increased when Alprazolam is combined with Vortioxetine.
Amiodarone
The serum concentration of Vortioxetine can be increased when it is combined with Amiodarone.
Amisulpride
The risk or severity of adverse effects can be increased when Amisulpride is combined with Vortioxetine.
Amitriptyline
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Amitriptyline.
Amobarbital
The risk or severity of adverse effects can be increased when Amobarbital is combined with Vortioxetine.
Amoxapine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Amoxapine.
Amphetamine
The metabolism of Vortioxetine can be decreased when combined with Amphetamine.
Anhydrous Tacrolimus
The metabolism of Tacrolimus can be decreased when combined with Vortioxetine.
Apalutamide
The serum concentration of Vortioxetine can be decreased when it is combined with Apalutamide.
Aprepitant
The serum concentration of Vortioxetine can be increased when it is combined with Aprepitant.
Aripiprazole
The risk or severity of adverse effects can be increased when Aripiprazole is combined with Vortioxetine.
Armodafinil
The metabolism of Vortioxetine can be decreased when combined with Armodafinil.
Artemether
The metabolism of Vortioxetine can be decreased when combined with Artemether.
Articaine
The risk or severity of adverse effects can be increased when Articaine is combined with Vortioxetine.
Asenapine
The risk or severity of adverse effects can be increased when Asenapine is combined with Vortioxetine.
Atazanavir
The metabolism of Vortioxetine can be decreased when combined with Atazanavir.
Atomoxetine
The metabolism of Vortioxetine can be decreased when combined with Atomoxetine.
Azelastine
Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Baclofen
The risk or severity of adverse effects can be increased when Baclofen is combined with Vortioxetine.
Barbital
The risk or severity of adverse effects can be increased when Barbital is combined with Vortioxetine.
Benoxinate
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Vortioxetine.
Benperidol
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Benperidol.
Benzocaine
The risk or severity of adverse effects can be increased when Benzocaine is combined with Vortioxetine.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Vortioxetine.
Betaxolol
The metabolism of Vortioxetine can be decreased when combined with Betaxolol.
Boceprevir
The metabolism of Vortioxetine can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Vortioxetine can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Vortioxetine can be decreased when it is combined with Bosentan.
Brexpiprazole
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Brexpiprazole.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.
Bromazepam
The risk or severity of adverse effects can be increased when Bromazepam is combined with Vortioxetine.
Bromocriptine
Bromocriptine may increase the vasoconstricting activities of Vortioxetine.
Bromperidol
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Bromperidol.
Brompheniramine
The risk or severity of adverse effects can be increased when Brompheniramine is combined with Vortioxetine.
Brotizolam
The risk or severity of adverse effects can be increased when Brotizolam is combined with Vortioxetine.
Bupivacaine
The risk or severity of adverse effects can be increased when Bupivacaine is combined with Vortioxetine.
Buprenorphine
Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Bupropion
The risk or severity of adverse effects can be increased when Bupropion is combined with Vortioxetine.
Buspirone
Buspirone may increase the serotonergic activities of Vortioxetine.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Vortioxetine.
Butalbital
The risk or severity of adverse effects can be increased when Butalbital is combined with Vortioxetine.
Butamben
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Butamben.
Butobarbital
The risk or severity of adverse effects can be increased when Butethal is combined with Vortioxetine.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Vortioxetine.
Cabergoline
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Cabergoline.
Capecitabine
The metabolism of Vortioxetine can be decreased when combined with Capecitabine.
Carbamazepine
The serum concentration of Vortioxetine can be decreased when it is combined with Carbamazepine.
Carbinoxamine
The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Vortioxetine.
Cariprazine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Cariprazine.
Carisoprodol
The risk or severity of adverse effects can be increased when Carisoprodol is combined with Vortioxetine.
Celecoxib
The metabolism of Vortioxetine can be decreased when combined with Celecoxib.
Ceritinib
The serum concentration of Vortioxetine can be increased when it is combined with Ceritinib.
Cetirizine
The risk or severity of adverse effects can be increased when Cetirizine is combined with Vortioxetine.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Vortioxetine.
Chloramphenicol
The metabolism of Vortioxetine can be decreased when combined with Chloramphenicol.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Vortioxetine.
Chlormethiazole
The risk or severity of adverse effects can be increased when clomethiazole is combined with Vortioxetine.
Chlormezanone
The risk or severity of adverse effects can be increased when Chlormezanone is combined with Vortioxetine.
Chloroprocaine
The risk or severity of adverse effects can be increased when Chloroprocaine is combined with Vortioxetine.
Chloroquine
The metabolism of Vortioxetine can be decreased when combined with Chloroquine.
Chlorpheniramine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Vortioxetine.
CHLORPHENIRAMINE POLISTIREX
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Vortioxetine.
Chlorpromazine
The metabolism of Vortioxetine can be decreased when combined with Chlorpromazine.
Chlorprothixene
The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Vortioxetine.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Vortioxetine.
Cholecalciferol
The metabolism of Vortioxetine can be decreased when combined with Cholecalciferol.
Cimetidine
The metabolism of Vortioxetine can be decreased when combined with Cimetidine.
Cinacalcet
The serum concentration of Vortioxetine can be increased when it is combined with Cinacalcet.
Citalopram
Citalopram may increase the serotonergic activities of Vortioxetine.
Clarithromycin
The metabolism of Vortioxetine can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Vortioxetine can be decreased when combined with Clemastine.
Clidinium
The risk or severity of adverse effects can be increased when Clidinium is combined with Vortioxetine.
Clidinium bromide
The risk or severity of adverse effects can be increased when Clidinium is combined with Vortioxetine.
Clobazam
The metabolism of Vortioxetine can be decreased when combined with Clobazam.
Clofezone
The metabolism of Vortioxetine can be decreased when combined with Rabeprazole.
Clomipramine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Clomipramine.
Clonazepam
The risk or severity of adverse effects can be increased when Clonazepam is combined with Vortioxetine.
Clonidine
The risk or severity of adverse effects can be increased when Clonidine is combined with Vortioxetine.
Clopidogrel
The metabolism of Vortioxetine can be decreased when combined with Clopidogrel.
Clorazepate
The risk or severity of adverse effects can be increased when Clorazepate is combined with Vortioxetine.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Clorazepate is combined with Vortioxetine.
Clotrimazole
The metabolism of Vortioxetine can be decreased when combined with Clotrimazole.
Clozapine
The metabolism of Vortioxetine can be decreased when combined with Clozapine.
Cobicistat
The serum concentration of Vortioxetine can be increased when it is combined with Cobicistat.
Cocaine
The serum concentration of Vortioxetine can be increased when it is combined with Cocaine.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Vortioxetine.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Vortioxetine.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Vortioxetine.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Vortioxetine.
Crisaborole
The metabolism of Vortioxetine can be decreased when combined with Crisaborole.
Crizotinib
The metabolism of Vortioxetine can be decreased when combined with Crizotinib.
Cyamemazine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Cyamemazine.
Cyclizine
The risk or severity of adverse effects can be increased when Cyclizine is combined with Vortioxetine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Cyclobenzaprine.
Cyclosporine
The metabolism of Vortioxetine can be decreased when combined with Cyclosporine.
Cyproheptadine
The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Vortioxetine.
Dabrafenib
The serum concentration of Vortioxetine can be decreased when it is combined with Dabrafenib.
Dantrolene
The risk or severity of adverse effects can be increased when Dantrolene is combined with Vortioxetine.
Dapiprazole
The risk or severity of adverse effects can be increased when Dapiprazole is combined with Vortioxetine.
Darifenacin
The metabolism of Vortioxetine can be decreased when combined with Darifenacin.
Darunavir
The serum concentration of Vortioxetine can be increased when it is combined with Darunavir.
Dasatinib
The serum concentration of Vortioxetine can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Vortioxetine can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Vortioxetine can be decreased when it is combined with Deferasirox.
Delavirdine
The serum concentration of Vortioxetine can be increased when it is combined with Delavirdine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Vortioxetine.
Desipramine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Desipramine.
Desloratadine
The risk or severity of adverse effects can be increased when Desloratadine is combined with Vortioxetine.
Desvenlafaxine
Desvenlafaxine may increase the serotonergic activities of Vortioxetine.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Vortioxetine.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Vortioxetine.
Dextromethorphan
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Dextromethorphan.
Dextromoramide
The risk or severity of adverse effects can be increased when Dextromoramide is combined with Vortioxetine.
Dezocine
The risk or severity of adverse effects can be increased when Dezocine is combined with Vortioxetine.
Diazepam
The risk or severity of adverse effects can be increased when Diazepam is combined with Vortioxetine.
Dibucaine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Vortioxetine.
Difenoxin
The risk or severity of adverse effects can be increased when Difenoxin is combined with Vortioxetine.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Vortioxetine.
Dihydroergotamine
Dihydroergotamine may increase the vasoconstricting activities of Vortioxetine.
Diltiazem
The metabolism of Vortioxetine can be decreased when combined with Diltiazem.
Dimenhydrinate
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Vortioxetine.
Diphenhydramine
The metabolism of Vortioxetine can be decreased when combined with Diphenhydramine.
Diphenoxylate
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Vortioxetine.
Dolasetron
Dolasetron may increase the serotonergic activities of Vortioxetine.
Dothiepin
The serum concentration of Vortioxetine can be increased when it is combined with Dosulepin.
Doxepin
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Doxepin.
Doxorubicin
The metabolism of Vortioxetine can be decreased when combined with Doxorubicin.
Doxorubicin Hydrochloride
The metabolism of Vortioxetine can be decreased when combined with Doxorubicin.
Doxycycline
The metabolism of Vortioxetine can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Vortioxetine can be decreased when combined with Doxycycline.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.
Dronedarone
The metabolism of Vortioxetine can be decreased when combined with Dronedarone.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.
Droxidopa
Vortioxetine may increase the hypertensive activities of Droxidopa.
Duloxetine
Duloxetine may increase the serotonergic activities of Vortioxetine.
Dyclonine
The risk or severity of adverse effects can be increased when Dyclonine is combined with Vortioxetine.
Efavirenz
The metabolism of Vortioxetine can be decreased when combined with Efavirenz.
Eletriptan
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Eletriptan.
Eliglustat
The metabolism of Vortioxetine can be decreased when combined with Eliglustat.
Enflurane
The risk or severity of adverse effects can be increased when Enflurane is combined with Vortioxetine.
Entacapone
The risk or severity of adverse effects can be increased when Entacapone is combined with Vortioxetine.
Enzalutamide
The serum concentration of Vortioxetine can be decreased when it is combined with Enzalutamide.
ergoloid mesylates, USP
Ergoloid mesylate may increase the vasoconstricting activities of Vortioxetine.
Ergonovine
Ergonovine may increase the vasoconstricting activities of Vortioxetine.
Ergotamine
Ergotamine may increase the vasoconstricting activities of Vortioxetine.
Erythromycin
The metabolism of Vortioxetine can be decreased when combined with Erythromycin.
Escitalopram
Escitalopram may increase the serotonergic activities of Vortioxetine.
Eslicarbazepine Acetate
The metabolism of Vortioxetine can be decreased when combined with Eslicarbazepine acetate.
Esomeprazole
The metabolism of Vortioxetine can be decreased when combined with Esomeprazole.
Estazolam
The risk or severity of adverse effects can be increased when Estazolam is combined with Vortioxetine.
Eszopiclone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Vortioxetine.
Ethanol
Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Vortioxetine.
Ethosuximide
The risk or severity of adverse effects can be increased when Ethosuximide is combined with Vortioxetine.
Ethotoin
The risk or severity of adverse effects can be increased when Ethotoin is combined with Vortioxetine.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Ethyl chloride.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Vortioxetine.
Ethylmorphine
The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Vortioxetine.
Etidocaine
The risk or severity of adverse effects can be increased when Etidocaine is combined with Vortioxetine.
Etifoxine
The risk or severity of adverse effects can be increased when Etifoxine is combined with Vortioxetine.
Etomidate
The risk or severity of adverse effects can be increased when Etomidate is combined with Vortioxetine.
Etravirine
The metabolism of Vortioxetine can be decreased when combined with Etravirine.
Ezogabine
The risk or severity of adverse effects can be increased when Ezogabine is combined with Vortioxetine.
Felbamate
The risk or severity of adverse effects can be increased when Felbamate is combined with Vortioxetine.
Felodipine
The metabolism of Vortioxetine can be decreased when combined with Felodipine.
Fentanyl
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Fentanyl.
Fexofenadine
The risk or severity of adverse effects can be increased when Fexofenadine is combined with Vortioxetine.
Flibanserin
The risk or severity of adverse effects can be increased when Flibanserin is combined with Vortioxetine.
Floxuridine
The metabolism of Vortioxetine can be decreased when combined with Floxuridine.
Fluconazole
The metabolism of Vortioxetine can be decreased when combined with Fluconazole.
Flunarizine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Vortioxetine.
Flunitrazepam
The risk or severity of adverse effects can be increased when Flunitrazepam is combined with Vortioxetine.
Fluorouracil
The metabolism of Vortioxetine can be decreased when combined with Fluorouracil.
Fluoxetine
The serum concentration of Vortioxetine can be increased when it is combined with Fluoxetine.
Flupenthixol
The risk or severity of adverse effects can be increased when Flupentixol is combined with Vortioxetine.
Fluphenazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Vortioxetine.
Flurazepam
The risk or severity of adverse effects can be increased when Flurazepam is combined with Vortioxetine.
Fluspirilene
The risk or severity of adverse effects can be increased when Fluspirilene is combined with Vortioxetine.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Vortioxetine.
Fluvastatin
The metabolism of Vortioxetine can be decreased when combined with Fluvastatin.
Fluvoxamine
The metabolism of Vortioxetine can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Vortioxetine can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Vortioxetine can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The serum concentration of Vortioxetine can be decreased when it is combined with Fosphenytoin.
Fospropofol
The risk or severity of adverse effects can be increased when Fospropofol is combined with Vortioxetine.
Frovatriptan
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Frovatriptan.
Furazolidone
The metabolism of Vortioxetine can be decreased when combined with Furazolidone.
Fusidate
The serum concentration of Vortioxetine can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Vortioxetine can be increased when it is combined with Fusidic Acid.
Gabapentin
The risk or severity of adverse effects can be increased when Gabapentin is combined with Vortioxetine.
Gabapentin Enacarbil
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Vortioxetine.
Gemfibrozil
The metabolism of Vortioxetine can be decreased when combined with Gemfibrozil.
Glutethimide
The risk or severity of adverse effects can be increased when Glutethimide is combined with Vortioxetine.
Granisetron
Granisetron may increase the serotonergic activities of Vortioxetine.
Guanfacine
The risk or severity of adverse effects can be increased when Guanfacine is combined with Vortioxetine.
Halazepam
The risk or severity of adverse effects can be increased when Halazepam is combined with Vortioxetine.
Haloperidol
The metabolism of Vortioxetine can be decreased when combined with Haloperidol.
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Vortioxetine.
Heroin
The risk or severity of adverse effects can be increased when Heroin is combined with Vortioxetine.
Hexobarbital
The risk or severity of adverse effects can be increased when Hexobarbital is combined with Vortioxetine.
Hydrocodone
Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Vortioxetine.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.
Hypoxis hemerocallidea root extract
The serum concentration of Vortioxetine can be decreased when it is combined with St. John's Wort.
Idelalisib
The metabolism of Vortioxetine can be decreased when combined with Idelalisib.
Iloperidone
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Iloperidone.
Imatinib
The metabolism of Vortioxetine can be decreased when combined with Imatinib.
Imipramine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Imipramine.
Indinavir
The metabolism of Vortioxetine can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Vortioxetine can be decreased when combined with Indinavir.
Iproniazid
The metabolism of Vortioxetine can be decreased when combined with Iproniazid.
Irbesartan
The metabolism of Vortioxetine can be decreased when combined with Irbesartan.
Isavuconazole
The serum concentration of Vortioxetine can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Vortioxetine can be decreased when combined with Isavuconazonium.
Isocarboxazid
The therapeutic efficacy of Vortioxetine can be increased when used in combination with Isocarboxazid.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Vortioxetine.
Isoniazid
The metabolism of Vortioxetine can be decreased when combined with Isoniazid.
Isradipine
The metabolism of Vortioxetine can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Vortioxetine can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Vortioxetine can be increased when it is combined with Ivacaftor.
Ketamine
The risk or severity of adverse effects can be increased when Ketamine is combined with Vortioxetine.
Ketazolam
The risk or severity of adverse effects can be increased when Ketazolam is combined with Vortioxetine.
Ketoconazole
The metabolism of Vortioxetine can be decreased when combined with Ketoconazole.
Lamotrigine
The risk or severity of adverse effects can be increased when Lamotrigine is combined with Vortioxetine.
Lapatinib
The metabolism of Vortioxetine can be decreased when combined with Lapatinib.
Leflunomide
The metabolism of Vortioxetine can be decreased when combined with Leflunomide.
Levetiracetam
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Vortioxetine.
Levobupivacaine
The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Vortioxetine.
Levocabastine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Levocabastine.
Levocetirizine
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Vortioxetine.
Levodopa
The risk or severity of adverse effects can be increased when Levodopa is combined with Vortioxetine.
Levomethadyl
The risk or severity of adverse effects can be increased when Levomethadyl Acetate is combined with Vortioxetine.
Levomilnacipran
Levomilnacipran may increase the serotonergic activities of Vortioxetine.
Levorphanol
The risk or severity of adverse effects can be increased when Levorphanol is combined with Vortioxetine.
Lidocaine
The risk or severity of adverse effects can be increased when Lidocaine is combined with Vortioxetine.
Linezolid
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Linezolid.
Lithium
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Lithium.
Lithium Cation
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Lithium.
Lopinavir
The serum concentration of Vortioxetine can be increased when it is combined with Lopinavir.
Loratadine
The risk or severity of adverse effects can be increased when Loratadine is combined with Vortioxetine.
Lorazepam
The risk or severity of adverse effects can be increased when Lorazepam is combined with Vortioxetine.
Lorcaserin
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Lorcaserin.
Lormetazepam
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Lormetazepam.
Losartan
The metabolism of Vortioxetine can be decreased when combined with Losartan.
Lovastatin
The metabolism of Vortioxetine can be decreased when combined with Lovastatin.
Loxapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Vortioxetine.
Luliconazole
The serum concentration of Vortioxetine can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Vortioxetine can be decreased when it is combined with Lumacaftor.
Lumefantrine
The metabolism of Vortioxetine can be decreased when combined with Lumefantrine.
Lurasidone
The risk or severity of adverse effects can be increased when Lurasidone is combined with Vortioxetine.
Magnesium Sulfate
The therapeutic efficacy of Vortioxetine can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Vortioxetine can be increased when used in combination with Magnesium sulfate.
Manidipine
The metabolism of Vortioxetine can be decreased when combined with Manidipine.
Maprotiline
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Maprotiline.
Meclizine
The risk or severity of adverse effects can be increased when Meclizine is combined with Vortioxetine.
Melatonin
The risk or severity of adverse effects can be increased when Melatonin is combined with Vortioxetine.
Meperidine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Pethidine.
Mephobarbital
The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Vortioxetine.
Mepivacaine
The risk or severity of adverse effects can be increased when Mepivacaine is combined with Vortioxetine.
Meprobamate
The risk or severity of adverse effects can be increased when Meprobamate is combined with Vortioxetine.
Mesoridazine
The risk or severity of adverse effects can be increased when Mesoridazine is combined with Vortioxetine.
Metaxalone
The risk or severity of adverse effects can be increased when Metaxalone is combined with Vortioxetine.
Methadone
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Methadone.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Methadyl Acetate is combined with Vortioxetine.
Methapyrilene
The risk or severity of adverse effects can be increased when Methapyrilene is combined with Vortioxetine.
Methaqualone
The risk or severity of adverse effects can be increased when Methaqualone is combined with Vortioxetine.
Methocarbamol
The risk or severity of adverse effects can be increased when Methocarbamol is combined with Vortioxetine.
Methohexital
The risk or severity of adverse effects can be increased when Methohexital is combined with Vortioxetine.
Methotrimeprazine
Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Vortioxetine.
Methsuximide
The risk or severity of adverse effects can be increased when Methsuximide is combined with Vortioxetine.
Methylene blue
The metabolism of Vortioxetine can be decreased when combined with Methylene blue.
Methylergonovine
Methylergometrine may increase the vasoconstricting activities of Vortioxetine.
Metoclopramide
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Metoclopramide.
Metoprolol
The metabolism of Vortioxetine can be decreased when combined with Metoprolol.
Metylperon
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Melperone.
Metyrosine
Vortioxetine may increase the sedative activities of Metyrosine.
Midazolam
The risk or severity of adverse effects can be increased when Midazolam is combined with Vortioxetine.
Midostaurin
The serum concentration of Vortioxetine can be increased when it is combined with Midostaurin.
Mifepristone
The serum concentration of Vortioxetine can be increased when it is combined with Mifepristone.
Milnacipran
Milnacipran may increase the serotonergic activities of Vortioxetine.
Minaprine
The metabolism of Vortioxetine can be decreased when combined with Minaprine.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.
Mirabegron
The metabolism of Vortioxetine can be decreased when combined with Mirabegron.
Mirtazapine
Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Mitotane
The serum concentration of Vortioxetine can be decreased when it is combined with Mitotane.
Moclobemide
The metabolism of Vortioxetine can be decreased when combined with Moclobemide.
Modafinil
The metabolism of Vortioxetine can be decreased when combined with Modafinil.
Molindone
The risk or severity of adverse effects can be increased when Molindone is combined with Vortioxetine.
Moricizine
The risk or severity of adverse effects can be increased when Moricizine is combined with Vortioxetine.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Vortioxetine.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.
Nalbuphine
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Vortioxetine.
Naratriptan
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Naratriptan.
Nefazodone
The metabolism of Vortioxetine can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Vortioxetine can be decreased when combined with Nelfinavir.
Netupitant
The serum concentration of Vortioxetine can be increased when it is combined with Netupitant.
Nevirapine
The serum concentration of Vortioxetine can be decreased when it is combined with Nevirapine.
Nialamide
The metabolism of Vortioxetine can be decreased when combined with Nialamide.
Nicardipine
The metabolism of Vortioxetine can be decreased when combined with Nicardipine.
Nicotine
The metabolism of Vortioxetine can be decreased when combined with Nicotine.
Nicotine Polacrilex
The metabolism of Vortioxetine can be decreased when combined with Nicotine.
Nilotinib
The metabolism of Vortioxetine can be decreased when combined with Nilotinib.
Nitrazepam
The risk or severity of adverse effects can be increased when Nitrazepam is combined with Vortioxetine.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Vortioxetine.
Norflurane
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Norflurane.
Normethadone
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Normethadone.
Nortriptyline
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Nortriptyline.
Olanzapine
The risk or severity of adverse effects can be increased when Olanzapine is combined with Vortioxetine.
Olaparib
The metabolism of Vortioxetine can be decreased when combined with Olaparib.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Vortioxetine.
Omeprazole
The metabolism of Vortioxetine can be decreased when combined with Omeprazole.
Ondansetron
Ondansetron may increase the serotonergic activities of Vortioxetine.
Opium
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Opium.
Orphenadrine
Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Osimertinib
The serum concentration of Vortioxetine can be increased when it is combined with Osimertinib.
Oxazepam
The risk or severity of adverse effects can be increased when Oxazepam is combined with Vortioxetine.
Oxprenolol
The risk or severity of adverse effects can be increased when Oxprenolol is combined with Vortioxetine.
Oxycodone
The risk or severity of adverse effects can be increased when Oxycodone is combined with Vortioxetine.
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Vortioxetine.
Palbociclib
The serum concentration of Vortioxetine can be increased when it is combined with Palbociclib.
Paliperidone
The risk or severity of adverse effects can be increased when Paliperidone is combined with Vortioxetine.
Palonosetron
Palonosetron may increase the serotonergic activities of Vortioxetine.
Panobinostat
The serum concentration of Vortioxetine can be increased when it is combined with Panobinostat.
Pantoprazole
The metabolism of Vortioxetine can be decreased when combined with Pantoprazole.
Paraldehyde
Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Vortioxetine.
Pargyline
The metabolism of Vortioxetine can be decreased when combined with Pargyline.
Paroxetine
The serum concentration of Vortioxetine can be increased when it is combined with Paroxetine.
Peginterferon Alfa-2b
The serum concentration of Vortioxetine can be decreased when it is combined with Peginterferon alfa-2b.
Pentazocine
The risk or severity of adverse effects can be increased when Pentazocine is combined with Vortioxetine.
Pentobarbital
The serum concentration of Vortioxetine can be decreased when it is combined with Pentobarbital.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.
Perazine
The risk or severity of adverse effects can be increased when Perazine is combined with Vortioxetine.
Periciazine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Propericiazine.
Perphenazine
The risk or severity of adverse effects can be increased when Perphenazine is combined with Vortioxetine.
Phenelzine
The metabolism of Vortioxetine can be decreased when combined with Phenelzine.
Phenobarbital
The serum concentration of Vortioxetine can be decreased when it is combined with Phenobarbital.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Phenoxyethanol.
Phenytoin
The serum concentration of Vortioxetine can be decreased when it is combined with Phenytoin.
Pimozide
The risk or severity of adverse effects can be increased when Pimozide is combined with Vortioxetine.
Pioglitazone
The metabolism of Vortioxetine can be decreased when combined with Pioglitazone.
Pipamperone
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Pipamperone.
Pipothiazine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Pipotiazine.
Pirinitramide
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Piritramide.
Pizotyline
The risk or severity of adverse effects can be increased when Pizotifen is combined with Vortioxetine.
Pomalidomide
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Vortioxetine.
Posaconazole
The metabolism of Vortioxetine can be decreased when combined with Posaconazole.
Pramipexole
Vortioxetine may increase the sedative activities of Pramipexole.
Pramoxine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Pramocaine.
Prazepam
The risk or severity of adverse effects can be increased when Prazepam is combined with Vortioxetine.
Pregabalin
The therapeutic efficacy of Vortioxetine can be increased when used in combination with Pregabalin.
Prilocaine
The risk or severity of adverse effects can be increased when Prilocaine is combined with Vortioxetine.
Primidone
The serum concentration of Vortioxetine can be decreased when it is combined with Primidone.
Procaine
The risk or severity of adverse effects can be increased when Procaine is combined with Vortioxetine.
Procarbazine
The metabolism of Vortioxetine can be decreased when combined with Procarbazine.
Prochlorperazine
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Vortioxetine.
Promazine
The metabolism of Vortioxetine can be decreased when combined with Promazine.
Promethazine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Promethazine.
Proparacaine
The risk or severity of adverse effects can be increased when Proparacaine is combined with Vortioxetine.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Vortioxetine.
Propoxyphene
The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Vortioxetine.
Prothipendyl
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Prothipendyl.
Protriptyline
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Protriptyline.
Pyrimethamine
The metabolism of Vortioxetine can be decreased when combined with Pyrimethamine.
Quazepam
The serum concentration of Vortioxetine can be increased when it is combined with Quazepam.
Quetiapine
The risk or severity of adverse effects can be increased when Quetiapine is combined with Vortioxetine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Quetiapine is combined with Vortioxetine.
Quinidine
The serum concentration of Vortioxetine can be increased when it is combined with Quinidine.
Quinine
The metabolism of Vortioxetine can be decreased when combined with Quinine.
Rabeprazole
The metabolism of Vortioxetine can be decreased when combined with Rabeprazole.
Ramelteon
The risk or severity of adverse effects can be increased when Ramelteon is combined with Vortioxetine.
Ranolazine
The metabolism of Vortioxetine can be decreased when combined with Ranolazine.
Rasagiline
The metabolism of Vortioxetine can be decreased when combined with Rasagiline.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Vortioxetine.
Remoxipride
The risk or severity of adverse effects can be increased when Remoxipride is combined with Vortioxetine.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Vortioxetine.
Rifabutin
The serum concentration of Vortioxetine can be decreased when it is combined with Rifabutin.
Rifampin
The serum concentration of Vortioxetine can be decreased when it is combined with Rifampicin.
Rifapentine
The serum concentration of Vortioxetine can be decreased when it is combined with Rifapentine.
Risperidone
The risk or severity of adverse effects can be increased when Risperidone is combined with Vortioxetine.
Ritonavir
The serum concentration of Vortioxetine can be increased when it is combined with Ritonavir.
Rizatriptan
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Rizatriptan.
Rolapitant
The metabolism of Vortioxetine can be decreased when combined with Rolapitant.
Ropinirole
Vortioxetine may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Ropivacaine is combined with Vortioxetine.
Rosiglitazone
The metabolism of Vortioxetine can be decreased when combined with Rosiglitazone.
Rotigotine
Vortioxetine may increase the sedative activities of Rotigotine.
Rucaparib
The metabolism of Vortioxetine can be decreased when combined with Rucaparib.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Vortioxetine.
Saquinavir
The metabolism of Vortioxetine can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Vortioxetine can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Vortioxetine can be decreased when used in combination with Sarilumab.
Scopolamine
The risk or severity of adverse effects can be increased when Scopolamine is combined with Vortioxetine.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Scopolamine is combined with Vortioxetine.
Secobarbital
The metabolism of Vortioxetine can be increased when combined with Secobarbital.
Selegiline
The metabolism of Vortioxetine can be decreased when combined with Selegiline.
Sertindole
The risk or severity of adverse effects can be increased when Sertindole is combined with Vortioxetine.
Sertraline
Sertraline may increase the serotonergic activities of Vortioxetine.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Vortioxetine.
Sildenafil
The metabolism of Vortioxetine can be decreased when combined with Sildenafil.
Siltuximab
The serum concentration of Vortioxetine can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Vortioxetine can be increased when it is combined with Simeprevir.
Sodium Oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.
Sorafenib
The metabolism of Vortioxetine can be decreased when combined with Sorafenib.
ST. JOHN'S WORT EXTRACT
The serum concentration of Vortioxetine can be decreased when it is combined with St. John's Wort.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Vortioxetine.
Sulfadiazine
The metabolism of Vortioxetine can be decreased when combined with Sulfadiazine.
Sulfamethoxazole
The metabolism of Vortioxetine can be decreased when combined with Sulfamethoxazole.
Sulfisoxazole
The metabolism of Vortioxetine can be decreased when combined with Sulfisoxazole.
Sulpiride
The risk or severity of adverse effects can be increased when Sulpiride is combined with Vortioxetine.
Sumatriptan
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Sumatriptan.
Sumatriptan Succinate
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Sumatriptan.
Suvorexant
Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tacrolimus
The metabolism of Tacrolimus can be decreased when combined with Vortioxetine.
Tamoxifen
The metabolism of Vortioxetine can be decreased when combined with Tamoxifen.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.
Tasimelteon
The risk or severity of adverse effects can be increased when Tasimelteon is combined with Vortioxetine.
Tedizolid
Tedizolid Phosphate may increase the serotonergic activities of Vortioxetine.
Tedizolid Phosphate
Tedizolid Phosphate may increase the serotonergic activities of Vortioxetine.
Telaprevir
The metabolism of Vortioxetine can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Vortioxetine can be decreased when combined with Telithromycin.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Vortioxetine.
Terbinafine
The serum concentration of Vortioxetine can be increased when it is combined with Terbinafine.
Teriflunomide
The metabolism of Vortioxetine can be decreased when combined with Teriflunomide.
Tetrabenazine
The risk or severity of adverse effects can be increased when Tetrabenazine is combined with Vortioxetine.
Tetracaine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Tetracaine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Tetracaine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.
Thalidomide
Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Thiamylal
The risk or severity of adverse effects can be increased when Thiamylal is combined with Vortioxetine.
Thiethylperazine
The risk or severity of adverse effects can be increased when Thiethylperazine is combined with Vortioxetine.
Thiopental
The risk or severity of adverse effects can be increased when Thiopental is combined with Vortioxetine.
Thiopental Sodium
The risk or severity of adverse effects can be increased when Thiopental is combined with Vortioxetine.
Thioproperazine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Thioproperazine.
Thioridazine
The serum concentration of Vortioxetine can be increased when it is combined with Thioridazine.
Thiotepa
The metabolism of Vortioxetine can be decreased when combined with Thiotepa.
Thiothixene
The risk or severity of adverse effects can be increased when Thiothixene is combined with Vortioxetine.
Tiagabine
The risk or severity of adverse effects can be increased when Tiagabine is combined with Vortioxetine.
Tiapride
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Tiapride.
Ticagrelor
The metabolism of Vortioxetine can be decreased when combined with Ticagrelor.
Ticlopidine
The metabolism of Vortioxetine can be decreased when combined with Ticlopidine.
Tipranavir
The serum concentration of Vortioxetine can be increased when it is combined with Tipranavir.
Tizanidine
The risk or severity of adverse effects can be increased when Tizanidine is combined with Vortioxetine.
Tocilizumab
The serum concentration of Vortioxetine can be decreased when it is combined with Tocilizumab.
Tolbutamide
The metabolism of Vortioxetine can be decreased when combined with Tolbutamide.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Vortioxetine.
Toloxatone
The metabolism of Vortioxetine can be decreased when combined with Toloxatone.
Topiramate
The metabolism of Vortioxetine can be decreased when combined with Topiramate.
Tramadol
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Tramadol.
Tranylcypromine
The metabolism of Vortioxetine can be decreased when combined with Tranylcypromine.
Trazodone
The risk or severity of adverse effects can be increased when Trazodone is combined with Vortioxetine.
Triazolam
The risk or severity of adverse effects can be increased when Triazolam is combined with Vortioxetine.
Triazulenone
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Loprazolam.
Trifluoperazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Vortioxetine.
Triflupromazine
The risk or severity of adverse effects can be increased when Triflupromazine is combined with Vortioxetine.
Trimeprazine
The risk or severity of adverse effects can be increased when Alimemazine is combined with Vortioxetine.
Trimethoprim
The metabolism of Vortioxetine can be decreased when combined with Trimethoprim.
Trimipramine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Trimipramine.
Triprolidine
The risk or severity of adverse effects can be increased when Triprolidine is combined with Vortioxetine.
Tropisetron
Tropisetron may increase the serotonergic activities of Vortioxetine.
Tryptophan
L-Tryptophan may increase the serotonergic activities of Vortioxetine.
Urethane
The risk or severity of adverse effects can be increased when Ethyl carbamate is combined with Vortioxetine.
Valproate
The risk or severity of adverse effects can be increased when Valproic Acid is combined with Vortioxetine.
Valproic Acid
The risk or severity of adverse effects can be increased when Valproic Acid is combined with Vortioxetine.
Valsartan
The metabolism of Vortioxetine can be decreased when combined with Valsartan.
Vemurafenib
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Vortioxetine.
Venlafaxine
Venlafaxine may increase the serotonergic activities of Vortioxetine.
Verapamil
The metabolism of Vortioxetine can be decreased when combined with Verapamil.
Vigabatrin
The risk or severity of adverse effects can be increased when Vigabatrin is combined with Vortioxetine.
Vilazodone
The risk or severity of adverse effects can be increased when Vilazodone is combined with Vortioxetine.
Voriconazole
The metabolism of Vortioxetine can be decreased when combined with Voriconazole.
Yohimbine
The therapeutic efficacy of Vortioxetine can be decreased when used in combination with Yohimbine.
Zafirlukast
The metabolism of Vortioxetine can be decreased when combined with Zafirlukast.
Zaleplon
The risk or severity of adverse effects can be increased when Zaleplon is combined with Vortioxetine.
Ziconotide
The risk or severity of adverse effects can be increased when Ziconotide is combined with Vortioxetine.
Ziprasidone
The metabolism of Vortioxetine can be decreased when combined with Ziprasidone.
Zolmitriptan
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Zolmitriptan.
Zolpidem
Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The risk or severity of adverse effects can be increased when Zonisamide is combined with Vortioxetine.
Zopiclone
The risk or severity of adverse effects can be increased when Zopiclone is combined with Vortioxetine.
Zotepine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Zotepine.
Zuclopenthixol
The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Vortioxetine.
